/Investor DB

Walden Catalyst — 2021 Investments

3 investments dated 2021 · listed companies and verified rows first · show all

Credocredosemi.comin𝕏NASDAQ: CRDOMay 2021SEC filingmedium confidence

Credo Semiconductor manufactures semiconductor products for data center and communications applications.

AI & Machine LearningCloud ComputingData & InfrastructureHardwareSemiconductorsSan Jose, US

Yat Tung Lam(Executive Officer, Director)Chi Fung Cheng(Executive Officer, Director)Lawrence Cheng(CTO and Founder)inJob Lam(COO and Founder)inDan Fleming(Executive Officer)inWilliam (Bill) Brennan(President, Chief Executive Officer and Director)

Board seatLip-Bu Tan· per SEC Form D · $57.4M raise · filed May 2021

Co-investorsCelesta CapitalCisco InvestmentsKluz VenturesSamsung Catalyst Fund

Medablemedable.comin𝕏Nov 2021SEC filingmedium confidence

Medable provides a cloud-based platform for clinical research that uses AI and digital tools to accelerate the development of therapies by improving the quality, reach, and efficiency of clinical trials.

AI & Machine LearningBiotechCloud ComputingDigital HealthHealthtechMedical DevicesSaaSPalo Alto, US

Michelle Longmire(Founder)Timothy R. Smith(Executive Officer, Director)Perry Robinson(Executive Officer)inRolland-Yves MauvernayTim Smith(Founder)

Board seatYoung A. Sohn· per SEC Form D · $304M raise · filed Nov 2021

Co-investorsACVC PartnersConnectivity VenturesDebiopharm Innovation FundHealthX VenturesInformed Ventures Advisors, LlcKin Ventures+7 more

SambaNova Systemssambanova.aiin𝕏Aug 2021

SambaNova develops an integrated AI platform designed to help enterprises deploy and manage AI workloads efficiently.

AI & Machine LearningCloud ComputingEnterprise SoftwareHardwareSemiconductorsPalo Alto, US

Kunle Olukotun(Founder)inRodrigo Liang(Founder)inChristopher Ré(Founder)

Board seatLip-Bu Tan· per SEC Form D

Co-investorsAtlantic Bridge VenturesBattery VenturesBerkeley FrontierCambium CapitalCelesta CapitalFelicis Ventures+21 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.